• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢浆液性囊腺癌预后的形态学标准。

Morphologic criteria for the prognosis of serous cystadenocarcinoma of the ovary.

作者信息

Geppert M, Smyczek-Gargya B

机构信息

Department of Obstetrics and Gynecology, University of Tübingen, Germany.

出版信息

Gynecol Obstet Invest. 1995;39(2):136-40. doi: 10.1159/000292395.

DOI:10.1159/000292395
PMID:7737584
Abstract

143 cases of serous ovarian cystadenocarcinoma were studied to establish the prognostic relevance of specific macroscopic and microscopic criteria. Significant differences in the survival rate were found depending on TNM classification, age, residual tumor mass, ascites, and degree of invasion. The prognosis was significantly better for normotypical or predominantly cystic tumors as well as for those with mononuclear infiltration, little histological atypia, or limited invasion. No prognostic relevance was found, however, for cytologic criteria such as Broder's grading and rate of mitosis.

摘要

对143例浆液性卵巢囊腺癌患者进行研究,以确定特定宏观和微观标准与预后的相关性。根据TNM分类、年龄、残留肿瘤肿块、腹水和浸润程度的不同,生存率存在显著差异。典型或主要为囊性的肿瘤,以及单核浸润、组织学异型性小或浸润有限的肿瘤,预后明显较好。然而,诸如布罗德分级和有丝分裂率等细胞学标准与预后无关。

相似文献

1
Morphologic criteria for the prognosis of serous cystadenocarcinoma of the ovary.卵巢浆液性囊腺癌预后的形态学标准。
Gynecol Obstet Invest. 1995;39(2):136-40. doi: 10.1159/000292395.
2
Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.恶性腹水在初诊时最常发生于高级别浆液性乳头状卵巢癌患者:2006 年至 2015 年在拜罗伊特医院治疗的 191 名女性的回顾性分析。
Arch Gynecol Obstet. 2019 Feb;299(2):515-523. doi: 10.1007/s00404-018-4952-9. Epub 2018 Nov 10.
3
[Clinical and pathological features of borderline ovarian tumors].[卵巢交界性肿瘤的临床及病理特征]
Zhonghua Fu Chan Ke Za Zhi. 2003 Feb;38(2):81-4.
4
[Construction and utilization of the prognostic model of serous ovarian adenocarcinoma].[浆液性卵巢腺癌预后模型的构建与应用]
Zhonghua Fu Chan Ke Za Zhi. 2006 Jul;41(7):459-63.
5
[Clinicopathologic features of 234 cases with borderline ovarian tumors].234例卵巢交界性肿瘤的临床病理特征
Zhonghua Fu Chan Ke Za Zhi. 2009 Feb;44(2):116-20.
6
[Assessment of prognostic factors in common ovarian tumors of varying malignancy].[不同恶性程度常见卵巢肿瘤的预后因素评估]
Magy Onkol. 2004;48(3):259-65. Epub 2004 Nov 1.
7
[Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas].[低级别和高级别卵巢浆液性癌中Pax2、p53和Ki-67的临床病理研究及免疫组化比较]
Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):511-6.
8
[Analysis of prognostic factors of epithelial ovarian carcinoma].[上皮性卵巢癌预后因素分析]
Zhonghua Fu Chan Ke Za Zhi. 2010 Feb;45(2):132-6.
9
Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.新辅助化疗后腹水消退对 IIIc 至 IV 期高级别浆液性卵巢癌治疗结局的预测作用
J Ovarian Res. 2016 Dec 2;9(1):85. doi: 10.1186/s13048-016-0294-z.
10
EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.EphA5蛋白,一种用于区分卵巢浆液性癌组织学分级和预后的潜在标志物。
J Ovarian Res. 2016 Nov 25;9(1):83. doi: 10.1186/s13048-016-0292-1.